B Capital Group — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.
BiotechHealthtech
Lyn Baranowski(CEO)in
Co-investorsAndera PartnersCatalio Capital Management, LPF-Prime CapitalInVivium CapitalNorwest Venture PartnersPivotal Life Sciences+9 more
Certn provides background screening and identity verification software for HR and talent acquisition teams, offering criminal record checks, credit and civil litigation checks, professional register verifications, and reference checks across multiple countries.
AI & Machine LearningCybersecurityGovTechHR TechSaaS
Andrew McLeod(Founder)inOwen Madrick(Founder)in
Co-investorsInovia CapitalAngel Collective Opportunity FundB4 CapitalBDC Growth Venture FundCyber Mentor FundMoxxie Ventures+13 more
DataRobot develops an AI and machine learning platform that automates model development and deployment for enterprises.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareBoston, US
Jeremy Achin(Founder)inTom de Godoy(Co-Founder and Former Chief Technology Officer)inThomas DeGodoy(Founder)Thomas de Godoy(Founder)
BoardHarry Weller(Director)Christopher Lynch(Director)in
Co-investors515 VenturesAliya Capital PartnersAMK Investment OfficeB4 CapitalBallistic VenturesCisco Investments+46 more
Numerion combines drug discovery expertise with machine learning and computational chemistry.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Alex Levy(Founder)inIzhar Wallach(Founder)inSteve Worland(CEO)inPamela Tsuruda(VP, Biology)Mark Sabat(VP, Medicinal Chemistry)inKate Stafford(VP, Machine Learning)in
Co-investorsB4 CapitalColorcon VenturesDCVC (Data Collective)Dolby Family VenturesNEXT CanadaY Combinator+12 more
SilverCloud by Amwell is a digital mental healthcare platform designed to provide mental health services to a broad audience.
Digital HealthHealthtechMental HealthWellness & Fitness
Co-investorsMemorialCare Innovation FundB4 CapitalFurthr VCOSF Ventures
Synack provides penetration testing and security assessments for enterprise security teams, combining AI agents with human testers to evaluate complex attack surfaces and protect critical infrastructure.
AI & Machine LearningCybersecurityEnterprise SoftwareRedwood City, US
Mark Kuhr(Founder)inJay Kaplan(Founder)inAngela Heindl-Schober(Chief Marketing Officer)inSteve Soper(Vice President of Legal)Rob Cross(Vice President, East)in
BoardTed Schlein(Director (Kleiner Perkins Caufield & Byers, later Ballistic Ventures))
Co-investorsALLEGIS CAPITALAllegisCyber CapitalB4 CapitalC5 CapitalG SquaredGV (Google Ventures)+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






























